Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Open-Label Extension Study of the Long-Term Safety of Vonaprument (ANX007) Administered by Intravitreal Injection in Participants With Dry Age-Related Macular Degeneration With Geographic Atrophy

NCT07807969 is registered in ClinicalTrials.gov with Annexon, Inc. as lead sponsor.

NCT NCT07807969
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07807969 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Open-Label Extension Study of the Long-Term Safety of Vonaprument (ANX007) Administered by Intravitreal Injection in Participants With Dry Age-Related Macular Degeneration With Geographic Atrophy
Lead sponsor
Annexon, Inc.
Phase
Phase 3
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
July 31, 2029
Enrollment
605 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

geographic atrophy